https://investorplace.com/earning-results/2024/08/vxrt-stock-earnings-vaxart-for-q2-of-2024/
VXRT stock results show that Vaxart missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
vxrtstockearningsvaxartmisses
https://www.fool.com/investing/2021/05/06/vaxart-has-3-advantages-over-pfizer-and-moderna/
Its coronavirus vaccine candidate may stand out, if upcoming trials are successful.
vaxartadvantagespfizermodernamotley
https://www.ainvest.com/news/vaxart-oral-pill-covid-19-vaccine-promising-alternative-mrna-vaccines-2501/
Vaxart's Oral Pill COVID-19 Vaccine: A Promising Alternative to mRNA Vaccines
vaxartoralpillcovidvaccine
https://vaxartsecuritieslitigation.com/
If You Purchased Vaxart, Inc. Common Stock or Options Between June 25, 2020, Through July 24, 2020, You May Be Part of This Litigation.
securities litigationvaxart
https://vaxart-inc.breezy.hr/
We are looking for great people to join our growing team!
doctitlevaxart
https://www.biospace.com/vaxart-to-host-first-quarter-2023-business-update-and-financial-results-conference-call-on-may-4
Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the first quarter ended March 31, 2023 after the...
first quarterbusiness updatevaxarthostfinancial